Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 9, 2019 at 12:00 PM EDT

Surprising Reaction to Lung Cancer Study Results

Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of…

Jon C. Ogg | Sep 5, 2019 at 2:00 PM EDT

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

NextCure appears to be one of those companies that has flown under the radar of the investing community since its…

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 13, 2019 at 11:00 AM EDT

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the…

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 28, 2019 at 8:50 AM EDT

Big Pharma Short Sellers Hike Their Bets

The May 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 22, 2019 at 11:40 AM EDT

How Eli Lilly Is Making Insulin More Affordable

Eli Lilly has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use…

Chris Lange | May 10, 2019 at 10:15 AM EDT

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 14 15 16 17 18 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Short Sellers Can’t Make Up Their Minds on Big Pharma

Surprising Reaction to Lung Cancer Study Results

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Big Pharma Sees a Rising Tide in Short Interest

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Short Sellers Seek Direction on Big Pharma

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

How Eli Lilly Is Making Insulin More Affordable

Big Pharma Scares Off Short Sellers

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

Eli Lilly : LLY

All Eli Lilly Articles

Short Sellers Can’t Make Up Their Minds on Big Pharma

Surprising Reaction to Lung Cancer Study Results

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Big Pharma Sees a Rising Tide in Short Interest

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Short Sellers Seek Direction on Big Pharma

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

How Eli Lilly Is Making Insulin More Affordable

Big Pharma Scares Off Short Sellers

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%